What Novo Nordisk, OpenAI and Pop Mart have in common
All three have suffered the curse of overnight success
EVERY chief executive dreams of it: a product so successful that it propels their company from obscurity to superstardom seemingly overnight.
Among the lessons from 2025, however, is that runaway success is not all upside. As the experience of whizzy chatbots, weight-loss jabs and wacky dolls illustrates, it brings problems, too.
The first pitfall is that bosses face the vexed task of scaling up their business to satisfy a level of demand that is impossible to predict.
TRENDING NOW
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
Cat A COE rate exceeds Cat B for third time in 4 months; premiums largely down
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
Manulife pulls loan product for rich Hong Kong clients after scrutiny